Tandem Diabetes Care Inc
TNDM
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.53B
Close$
$-3.23
113.8% downside
Current Fair Value
113.8% downsideOvervalued by 113.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.53 Billion |
|---|---|
| Enterprise Value | $2.22 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.04 |
| Beta | 1.58 |
| Outstanding Shares | 68,397,000 |
Return
| Return on Equity | -48.56% |
|---|---|
| Return on Assets | -5.49% |
| Return on Invested Capital | -5.57% |
Valuation & Multiples
| P/E Ratio | -24.1 |
|---|---|
| PEG | 40.43 |
| Price to Sales | 1.56 |
| Price to Book Ratio | 23.44 |
| Enterprise Value to Revenue | 2.13 |
| Enterprise Value to EBIT | -44.18 |
| Enterprise Value to Net Income | -36 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 5.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$254.99 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$266.12 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 319.0000▲ 31893.54% |
|---|---|
| Total Calls | 100▼ 100.00% |
| Total Puts | 31,900▼ 90.96% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 32.89%▼ 82.76% |
|---|---|
| Total Invested | $339.45M▼ 77.49% |
| Investors Holding | 104▼ 181.00% |
ESG Score
No data
About Tandem Diabetes Care Inc
1,600 employees
CEO: John Sheridan Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach t...